BC
HMLZ
RMGRACJVLBPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Beam Therapeuticsbeamtx.com GS RM JV |
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a | Cambridge, Massachusetts | 201-1000 | — |
Editas Medicineeditasmedicine.com FPLBJX |
Editas Medicine is a clinical-stage genome editing company that develops CRISPR-based medicines for serious diseases, with a pipel | Cambridge, Massachusetts | 51-200 | — |
Intelliatxintelliatx.com  SC BS NC |
Intellia Therapeutics is a clinical-stage biopharmaceutical company developing CRISPR-based gene editing therapies to treat severe | Cambridge, Massachusetts | 201-1000 | — |
CRISPR Therapeuticscrisprtx.com JOPPEF |
CRISPR Therapeutics is a gene-editing biotechnology company pioneering CRISPR-based medicines, with CASGEVY™ — the first-ever appr | Boston, Massachusetts | 201-1000 | — |
Verve Therapeuticsvervetx.com RF  AKKR |
Verve Therapeutics is a wholly owned subsidiary of Eli Lilly and Company developing a new class of genetic medicines for cardiovas | Boston, Massachusetts | 51-200 | — |
Caribou Biosciencescariboubio.com  RK CH SG |
Caribou Biosciences is a clinical-stage biopharmaceutical company developing off-the-shelf, allogeneic CAR-T cell therapies using | Berkeley, California | 51-200 | — |
AGTCagtc.com JO  KHIZ |
AGTC is a clinical-stage biotechnology company developing gene therapy products for severe inherited diseases of the eye, with an | Alachua, Florida | 51-200 | — |
Castle Creek Biosciencescastlecreekbio.com  SS AM RW |
Castle Creek Biosciences is a late-clinical stage regenerative medicine company developing novel gene therapies for patients with | Exton, Pennsylvania | 11-50 | — |
Ionis Pharmaceuticalsionispharma.com |
Ionis Pharmaceuticals is a biotechnology company founded in 1989 that specializes in the discovery and development of RNA-targeted | Carlsbad, California | 201-1000 | — |
Ksqtxksqtx.com  MB KWDS |
KSQ Therapeutics is a CRISPR-based biopharmaceutical company in Cambridge, Massachusetts that uses its CRISPRomics® genome-scale f | Lexington, Massachusetts | 51-200 | — |
Logicbiologicbio.com |
— | — | — | |
Addition Therapeuticsadditiontx.com  PP HH HR |
Addition Therapeutics is a biotechnology company developing a pipeline of PRINTed genetic medicines for patients with severe lifel | South San Francisco, California | 51-200 | — |
Genetherapysciencesgenetherapysciences.com |
— | — | — | |
Arbor Biotechnologiesarbor.bio  DH DMJM |
Arbor Biotechnologies is a next-generation gene editing company based in Cambridge, Massachusetts, developing potentially curative | Cambridge, Massachusetts | 51-200 | — |
Alnylamalnylam.com  KF AL KD |
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNAi therapeutics, developing medicines that silence | Cambridge, Massachusetts | 1001-5000 | — |
Aera Therapeuticsaeratx.com |
Aera is a delivery-first genetic medicines company developing proprietary delivery platforms — targeted lipid nanoparticles (tLNPs | Cambridge, Massachusetts | 51-200 | — |
Dicerna Pharmaceuticalsdicerna.com |
Dicerna Pharmaceuticals is a biotechnology company developing innovative treatments for rare inherited diseases, with operations b | Lexington, Massachusetts | 201-1000 | — |
Crispertxcrispertx.com |
— | — | — | |
Passage Biopassagebio.com |
Passage Bio is a clinical-stage genetic medicines company developing one-time therapies to treat neurodegenerative diseases, with | Philadelphia, Pennsylvania | 11-50 | — |
Sirnaomicssirnaomics.com |
Sirnaomics is a clinical-stage RNA therapeutics biopharmaceutical company that discovers and develops RNA drugs for indications wi | Germantown, Maryland | 11-50 | — |
BreezeBiobreezebio.com |
BreezeBio is a biotechnology company developing precision genetic medicines enabled by its proprietary NanoGalaxy® platform, which | Brisbane, California | 51-200 | — |
Eidostxeidostx.com |
Eidos Therapeutics is a clinical-stage biotechnology company developing novel, genetically targeted therapies to treat disease, wi | San Francisco, California | 51-200 | — |
Adverum Biotechnologiesadverum.com |
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company developing Ixo-vec, an investigational AAV gene t | Redwood City, California | 51-200 | — |
Sarepta Therapeuticssarepta.com |
Sarepta Therapeutics is a global biopharmaceutical company headquartered in Cambridge, Massachusetts, that engineers precision gen | Cambridge, Massachusetts | 1001-5000 | — |
Calimmunecalimmuneinc.com |
Calimmune is a biotechnology company founded in 2006 that develops gene therapy technologies to treat chronic and currently incura | Pasadena, California | 51-200 | — |
Pregenenbluebirdbio.com |
Genetix Biotherapeutics (formerly bluebird bio) is a privately held, Boston-area gene therapy company developing first-in-class, o | Seattle, Washington | 1-10 | — |
Genetherapysystemsgenetherapysystems.com |
— | — | — | |
Akero Therapeuticsakerotx.com |
Akero Therapeutics is a clinical-stage biopharmaceutical company developing Efruxifermin (EFX), a novel therapy for metabolic dysf | South San Francisco, California | 51-200 | — |
Arrowhead Pharmaceuticalsarrowheadpharma.com |
Arrowhead Pharmaceuticals is a biotechnology company developing RNAi therapeutics to treat hard-to-treat diseases, with a TRiM™ RN | Pasadena, California | 201-1000 | — |
Apellis Pharmaceuticalsapellis.com |
Apellis Pharmaceuticals is a biotechnology company founded in 2008 that develops complement science therapies to treat patients wi | Waltham, Massachusetts | 201-1000 | — |
| Run live for more | ||||
Beam Therapeutics is a CRISPR base editing biotechnology company founded in 2017 and headquartered in Cambridge, MA, developing a portfolio of precision genetic medicines to treat serious diseases.
Companies like Beam Therapeutics include Editas Medicine, Intelliatx, CRISPR Therapeutics, Verve Therapeutics, Caribou Biosciences. See the full list of 24 competitors and alternatives above.
Beam Therapeutics has approximately 201-1000 employees and is in the Biotechnology Research industry.
Beam Therapeutics is headquartered in Cambridge, Massachusetts.
Beam Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Beam Therapeutics are listed above, including leaders across executive, finance, sales and operations.